How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,700 results for

Gestational Diabetes Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Metformin vs exercise vs vitamin D vs probiotics for the prevention of gestational diabetes mellitus, in women at high risk of gestational diabetes mellitus: a network meta-analysis

Metformin vs exercise vs vitamin D vs probiotics for the prevention of gestational diabetes mellitus, in women at high risk of gestational diabetes mellitus: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility (...) will yield the same results as the fixed-effect model. For further details, see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than

2019 PROSPERO

82. Investigation and Management Small-for-Gestational-Age Fetus

Investigation and Management Small-for-Gestational-Age Fetus The Investigation and Management of the Small–for–Gestational–Age Fetus Green–top Guideline No. 31 2nd Edition | February 2013 | Minor revisions – January 2014RCOG Green-top Guideline No. 31 2of 34 © Royal College of Obstetricians and Gynaecologists The Investigation and Management of the Small–for–Gestational–Age Fetus This is the second edition of this guideline. It replaces the first edition which was published in November 2002 (...) . 11.2 Near term / term SGA fetus One randomised equivalence trial exists comparing the effect of induction of labour or expectant monitoring in women beyond 36 weeks of gestation with suspected FGR (defined as a fetal AC or EFW 40 years 22 † BW 34 weeks if static growth over 3weeks Recommend steroids if delivery is by CS (as per RCOG guidance) Repeat ultrasound (Fortnightly) Fetal biometry Single AC or EFW 34 weeks if static growth over 3 weeks Recommend steroids if delivery is by CS (as per RCOG

2013 Royal College of Obstetricians and Gynaecologists

83. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the US Preventive Services Task Force and National Institutes of Health Office of Medical Applications of Research

diagnosed with gestational diabetes mellitus (including foetal surveillance protocols) were required in order to guide obstetric investigations and management of gestational diabetes mellitus. Funding Agency for Healthcare Research and Quality, USA. Bibliographic details Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the US Preventive Services Task Force and National Institutes (...) : a systematic review and meta-analysis for the US Preventive Services Task Force and National Institutes of Health Office of Medical Applications of Research Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L CRD summary This well-conducted review concluded that treating gestational diabetes mellitus resulted in less pre-eclampsia, shoulder dystocia and macrosomia compared with no treatment. The evidence did not show an effect on neonatal hypoglycaemia or future poor metabolic outcomes

2013 DARE.

84. Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force

Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM CRD summary This review concluded that the oral glucose challenge test and fasting plasma glucose could identify women (...) L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM. Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force. Annals of Internal Medicine 2013; 159(2): 115-122 Original Paper URL Additional Data URL Other publications of related interest Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Screening and diagnosing gestational diabetes mellitus. Rockville, MD, USA: Agency for Healthcare

2013 DARE.

85. Metformin versus Insulin in the Management of Pre-Gestational Diabetes Mellitus in Pregnancy and Gestational Diabetes Mellitus at the Korle Bu Teaching Hospital: A Randomized Clinical Trial. Full Text available with Trip Pro

Metformin versus Insulin in the Management of Pre-Gestational Diabetes Mellitus in Pregnancy and Gestational Diabetes Mellitus at the Korle Bu Teaching Hospital: A Randomized Clinical Trial. To determine if metformin monotherapy or metformin in combination with insulin is equally effective as insulin monotherapy at glycemic control in diabetes mellitus in pregnancy among Ghanaians.This was a study involving 104 pregnant women with type 2 diabetes mellitus (T2DM) or gestational diabetes mellitus (...) weeks.The two hour post prandial blood glucose (2HPG) levels were significantly lower in the metformin group than the insulin group (p= 0.004).The findings of this study suggest that metformin monotherapy is effective in achieving glycemic targets in the management of diabetes in pregnancy. It is more effective than insulin in lowering the 2HPG level.Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12614000942651.

2015 PloS one Controlled trial quality: uncertain

86. Growing evidence that maternal gestational diabetes increases risk of autism in offspring

Growing evidence that maternal gestational diabetes increases risk of autism in offspring Growing evidence that maternal gestational diabetes increases risk of autism in offspring | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Growing evidence that maternal gestational diabetes increases risk of autism in offspring Article Text Causes and risk factors Growing evidence that maternal gestational diabetes increases risk of autism in offspring

2015 Evidence-Based Mental Health

87. Induction of labor versus expectant management of large-for-gestational-age infants in nulliparous women. Full Text available with Trip Pro

Induction of labor versus expectant management of large-for-gestational-age infants in nulliparous women. There is no apparent consensus on obstetric management, i.e., induction of labor or expectant management of women with suspected large-for-gestational-age (LGA)-fetuses.To further examine the subject, a nationwide population-based cohort study from the Swedish Medical Birth Register in nulliparous non-diabetic women with singleton, vertex LGA (>90th centile) births, 1992-2013, was performed (...) . Delivery of a live-born LGA infant induced at 38 completed weeks of gestation in non-preeclamptic pregnancies, was compared to those of expectant management, with delivery at 39, 40, 41, or 42 completed weeks of gestation and beyond, either by labor induction or via spontaneous labor. Primary outcome was mode of delivery. Secondary outcomes included obstetric anal sphincter injury, 5-minute Apgar<7 and birth injury. Multivariable logistic regression analysis was performed to control for potential

2017 PLoS ONE

88. Dietary Intervention, Gestational Weight Gain and Gestational Diabetes.

Dietary Intervention, Gestational Weight Gain and Gestational Diabetes. Dietary Intervention, Gestational Weight Gain and Gestational Diabetes. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Dietary (...) groups. Condition or disease Intervention/treatment Phase Dietary Habits Gestational Diabetes Weight Gain Overweight and Obesity Behavioral: Dietary intervention Not Applicable Detailed Description: Half of the women are allocated to the intervention group and another half for the control group. The intervention group will get written material of healthy diet during pregnancy as well as emphasized nutritional guidance given by public health nurses at each visit in the maternity care clinic

2017 Clinical Trials

89. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada

Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada A Publication of the Professional Sections of the Canadian Diabetes Association Une publication des sections professionnelles de l'Association canadienne du diab ete CONTENTS: April 2013 - Volume 37 - Supplement 1 S1 Introduction S4 Methods S8 De?nition, Classi?cation and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome S12 Screening for Type 1 and Type 2 Diabetes (...) S16 Reducing the Risk of Developing Diabetes Management S20 Organization of Diabetes Care S26 Self-Management Education S31 Targets for Glycemic Control S35 Monitoring Glycemic Control S40 Physical Activity and Diabetes S45 NutritionTherapy S56 Pharmacotherapy inType 1 Diabetes S61 Pharmacologic Management of Type 2 Diabetes S69 Hypoglycemia S72 Hyperglycemic Emergencies in Adults S77 In-hospital Management of Diabetes S82 Weight Management in Diabetes S87 Diabetes and Mental Health S93 In?uenza

2013 CPG Infobase

90. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada : Introduction

Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada : Introduction My Site - Chapter 1: Introduction Diabetes Canada | Clinical Practice Guidelines The Canadian Diabetes Association has become Diabetes Canada* Search: Guidelines Key Messages For Health-Care Providers For People with Diabetes Other Languages Links Introduction Diabetes Canada Clinical Practice Guidelines Expert Committee Robyn L. Houlden MD, FRCPC Key Messages (...) Recommendations Figures Full Text References Chapter Headings Welcome to the Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada . Updated every five years, these comprehensive, evidence-based guidelines represent the sixth set since their introduction in 1992; and the first under the new name of Diabetes Canada. In 2017, the name of the Canadian Diabetes Association was changed to Diabetes Canada to reflect the seriousness of diabetes, and to increase

2013 CPG Infobase

91. Baby Steps - a structured group education programme with accompanying mobile web application designed to promote physical activity in women with a history of gestational diabetes: study protocol for a randomised controlled trial. Full Text available with Trip Pro

Baby Steps - a structured group education programme with accompanying mobile web application designed to promote physical activity in women with a history of gestational diabetes: study protocol for a randomised controlled trial. A diagnosis of gestational diabetes (GDM) is associated with an over sevenfold increase in the risk of developing type 2 diabetes (T2D), while among parous women with T2D, up to 30% have a history of GDM. Lifestyle interventions have been shown to reduce the risk (...) of incident T2D in adults with impaired glucose tolerance, including in women with a history of GDM. The aim of this study is to establish whether a group self-management education programme, supported by a mobile web application, can improve levels of physical activity at 12 months in women who have had GDM.The study is a randomised controlled trial with follow-up at 6 and 12 months. Primary outcome is change in objectively measured average daily physical activity at 12 months. Secondary outcomes include

2018 Trials Controlled trial quality: uncertain

92. Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women. Full Text available with Trip Pro

Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women.  To assess the effectiveness of metformin in the incidence of gestational diabetes mellitus (GDM) in obese pregnant women attending a public maternity hospital in Joinville, Santa Catarina, Brazil. Randomized clinical trial including obese pregnant women with a body mass index (BMI) ≥ 30 kg/m2, divided into two groups (control and metformin). Both groups received guidance regarding diet (...) and physical exercise. The participants were assessed at two moments, the first at enrollment (gestational age ≤ 20) and the second at gestational weeks 24-28. The outcomes assessed were BMI and gestational diabetes mellitus (GDM) diagnosis. The data distribution was assessed with the Friedman test. For all the analytical models, the p-values were considered significant when lower than 0.05. The absolute risk reduction was also estimated. Overall, 164 pregnant women were assessed and further divided

2018 Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia Controlled trial quality: uncertain

93. A randomized lifestyle intervention preventing gestational diabetes: effects on self-rated health from pregnancy to postpartum. (Abstract)

A randomized lifestyle intervention preventing gestational diabetes: effects on self-rated health from pregnancy to postpartum. The purpose was to examine the effects of a randomized lifestyle intervention on self-rated health from pregnancy to postpartum in participants at high risk for gestational diabetes mellitus.We included 266 women with a history of gestational diabetes and/or prepregnancy BMI ≥30 kg/m2. The intervention group (n = 144) received individualized counseling on diet (...)  = 0.064).The self-rated health level varied over time from the first trimester of pregnancy to 12 months postpartum in women at risk for gestational diabetes. Improving self-rated health among high-risk pregnant women through lifestyle intervention calls for further research.

2018 Journal of psychosomatic obstetrics and gynaecology Controlled trial quality: uncertain

94. The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial. (Abstract)

The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial. The role of gut microbiota in the management of diabetes is shown. In this randomized clinical trial we assessed the effects of synbiotic supplementation on insulin, lipid profile and antioxidative status among women with gestational diabetes mellitus (GDM).Ninety

2018 Diabetes research and clinical practice Controlled trial quality: predicted high

95. Proinsulin in the identification and risk stratification of gestational diabetes mellitus: study protocol for a prospective, longitudinal cohort study. Full Text available with Trip Pro

Proinsulin in the identification and risk stratification of gestational diabetes mellitus: study protocol for a prospective, longitudinal cohort study. Gestational diabetes mellitus (GDM) is a common metabolic disorder occurring in up to 10% of pregnancies in the western world. Most women with GDM are asymptomatic; therefore, it is important to screen, diagnose and manage the condition as it is associated with an increased risk of maternal and perinatal complications. Diagnosis of GDM is made (...) tolerance tests will be carried out at 16-18 and 24-28 weeks gestation in 200 pregnant women with at least one risk factor for GDM (body mass index>30 kg/m2, previous macrosomic baby (>4.5 kg), previous gestational diabetes, first degree relative with type 2 diabetes mellitus) recruited from antenatal clinics. Blood samples will be taken fasting and at 30 min, 1 and 2 hours following the 75 g glucose load. In addition, a fasting blood sample will be taken 6-weeks post delivery. All samples

2018 BMJ open

96. The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes

The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes (TESGO) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03523143

2018 Clinical Trials

97. Effect of Suplementation of Vitamin D in Gestational Diabetes Mellitus

Effect of Suplementation of Vitamin D in Gestational Diabetes Mellitus Effect of Suplementation of Vitamin D in Gestational Diabetes Mellitus - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect (...) of Suplementation of Vitamin D in Gestational Diabetes Mellitus The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03645109 Recruitment Status : Not yet recruiting First Posted : August 24, 2018 Last Update Posted : August 24, 2018 See

2018 Clinical Trials

98. Fetal Interventricular Septum Thickness and Maternal Gestational Diabetes Control

Fetal Interventricular Septum Thickness and Maternal Gestational Diabetes Control Fetal Interventricular Septum Thickness and Maternal Gestational Diabetes Control - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) diabetes mellitus is associated with increased incidence of macrosomia, operative vaginal delivery, shoulder dystocia, cesarean delivery, metabolic complications in the newborn and long-term risk of developing type II diabetes mellitus (HAPO 2008). Early diagnosis and management of gestational diabetes mellitus, including dietary advice and insulin, improves maternal and fetal outcomes (Crowther 2005, Hartling 2013). Various strategies have been tested prenatally to detect those fetuses that might

2018 Clinical Trials

99. The Relation Between Vitamin D and Gestational Diabetes Mellitus

The Relation Between Vitamin D and Gestational Diabetes Mellitus The Relation Between Vitamin D and Gestational Diabetes Mellitus - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Relation Between Vitamin (...) D and Gestational Diabetes Mellitus The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03665974 Recruitment Status : Completed First Posted : September 11, 2018 Last Update Posted : September 11, 2018 Sponsor: Hacettepe University Information provided by (Responsible Party): F. Gülhan Samur

2018 Clinical Trials

100. Gestational diabetes incidence and delivery outcomes in Western China: A prospective cohort study. Full Text available with Trip Pro

Gestational diabetes incidence and delivery outcomes in Western China: A prospective cohort study. Few studies have examined the age-standardized incidence of gestational diabetes mellitus (GDM) for comparison between populations. Information on delivery outcomes is also lacking for Chinese women with GDM. Therefore, the present study aimed to determine age-standardized GDM incidence and assess its association with maternal and neonatal outcomes.A total of 1901 pregnant women were recruited (...) gestation at delivery, and a higher risk of cesarean delivery. Their newborns were more likely to be macrosomic or small for gestational age, and to require neonatal intensive care.The incidence of GDM was high in Western China, especially among older and overweight women. Moreover, women with GDM had higher rates of adverse delivery outcomes. The findings lend further support for the screening, prevention, and management of GDM in Chinese women.© 2018 Wiley Periodicals, Inc.

2018 Birth

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>